These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20368235)

  • 21. [Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group].
    Störk S; Ertl G; Nitschmann S
    Internist (Berl); 2010 May; 51(5):674-6. PubMed ID: 20352177
    [No Abstract]   [Full Text] [Related]  

  • 22. Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Brooks MM; Chung SC; Helmy T; Hillegass WB; Escobedo J; Melsop KA; Massaro EM; McBane RD; Hyde P; Hlatky MA;
    Circulation; 2010 Oct; 122(17):1690-9. PubMed ID: 20937978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapies for type 2 diabetes and coronary artery disease.
    DeVries JH
    N Engl J Med; 2009 Oct; 361(14):1408-9; author reply 1409-10. PubMed ID: 19802918
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial.
    Wolk R; Bertolet M; Brooks MM; Pratley RE; Sobel BE; Frye RL; Singh P; Calvin AD; Rutter MK; Mooradian AD; Somers VK;
    Eur J Prev Cardiol; 2016 Jan; 23(1):50-8. PubMed ID: 25073857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D).
    Schwartz L; Bertolet M; Feit F; Fuentes F; Sako EY; Toosi MS; Davidson CJ; Ikeno F; King SB
    Circ Cardiovasc Interv; 2012 Apr; 5(2):166-73. PubMed ID: 22496082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Brooks MM; Chaitman BR; Nesto RW; Hardison RM; Feit F; Gersh BJ; Krone RJ; Sako EY; Rogers WJ; Garber AJ; King SB; Davidson CJ; Ikeno F; Frye RL;
    Circulation; 2012 Oct; 126(17):2115-24. PubMed ID: 23008442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Goldfine AB; Fonseca V
    Circulation; 2010 Jun; 121(22):2447-9. PubMed ID: 20530022
    [No Abstract]   [Full Text] [Related]  

  • 29. Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Sobel BE; Hardison RM; Genuth S; Brooks MM; McBane RD; Schneider DJ; Pratley RE; Huber K; Wolk R; Krishnaswami A; Frye RL;
    Circulation; 2011 Aug; 124(6):695-703. PubMed ID: 21768545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved.
    Greason KL; Schaff HV
    Coron Artery Dis; 2010 Nov; 21(7):402-6. PubMed ID: 20706113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ancillary studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial: Synergies and opportunities.
    Sobel BE;
    Am J Cardiol; 2006 Jun; 97(12A):53G-58G. PubMed ID: 16813738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choice of initial medical therapy vs. prompt coronary revascularization in patients with type 2 diabetes and stable ischemic coronary disease with special emphasis on the BARI 2D trial results.
    Chaitman BR; Hadid M; Laddu AA
    Curr Opin Cardiol; 2010 Nov; 25(6):597-602. PubMed ID: 20885315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statement of the problem.
    Steiner G;
    Am J Cardiol; 2006 Jun; 97(12A):3G-8G. PubMed ID: 16813733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different effects of thiazolidinediones on target vessel revascularization with bare metal stents: a meta-analysis.
    Nishio K; Kobayashi Y
    Cardiovasc Revasc Med; 2010; 11(4):227-31. PubMed ID: 20934654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General cardiology perspective: decision making regarding revascularization of patients with type 2 diabetes mellitus and cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Fuster V; Farkouh ME
    Circulation; 2010 Jun; 121(22):2450-2. PubMed ID: 20530023
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter by Liu et al regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
    Liu W; Chen M; Huang DJ
    Circulation; 2014 Apr; 129(16):e459. PubMed ID: 24753556
    [No Abstract]   [Full Text] [Related]  

  • 37. BARI 2D: A Reanalysis Focusing on Cardiovascular Events.
    Genuth SM; Vlachos H; Brooks MM; Bantle JP; Chaitman BR; Green J; Kelsey SF; King SB; McBane R; Sako EY; Schneider DJ; Steffes M; Frye RL;
    Mayo Clin Proc; 2019 Nov; 94(11):2249-2262. PubMed ID: 31590967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.